HC Wainwright & Co. Maintains Buy on Celcuity, Raises Price Target to $185
Celcuity Inc CELC
$132.18
▼ -3.99%
($-5.50)
Open
$139.80
Prev Close
$137.68
Day Range
$129.02 – $139.80
52W Range
$9.51 – $151.02
Market Cap
$6.71B
Beta
0.12
EPS (TTM)
$-3.78
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-09-20 |
| Shares Out. | 48,340,000 |
| Website | celcuity.com/ ↗ |
| Phone | 13026587581 |
Celcuity Inc is a publicly traded company under the ticker symbol CELC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)
📰 Latest News for CELC
Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst
Wells Fargo Maintains Overweight on Celcuity, Raises Price Target to $183
Needham Reiterates Buy on Celcuity, Maintains $157 Price Target
Celcuity Inc. (NASDAQ:CELC) Q1 Earnings Beat Forecasts, But Stock Drops on Phase 3 Data Focus
Celcuity Inc. (CELC) Q1 2026 Earnings Call Transcript
Transcript: Celcuity Q1 2026 Earnings Conference Call
Celcuity Q1 Adj. EPS $(0.86) Beats $(1.05) Estimate